Showing 7921-7930 of 18164 results for "".
The Role of HER2-Directed Therapy for Second-Line Treatment of HER2+ Metastatic Breast Cancer
https://reachmd.com/programs/cme/the-role-of-her2-directed-therapy-for-second-line-treatment-of-her2-metastatic-breast-cancer/29828/Join our expert faculty as they review the current guidelines for breast cancer and the clinical trial data supporting these recommendations.Expert Viewpoint: Optimizing Breast Cancer Treatment
https://reachmd.com/programs/cme/expert-viewpoint-optimizing-breast-cancer-treatment/29832/Join our expert faculty as they review the current guidelines for breast cancer and the clinical trial data supporting these recommendations.Understanding Endocrine Resistance in HR+/HER2- mBC
https://reachmd.com/programs/cme/Understanding-Endocrine-Resistance-in-HR-HER2-mBC/37323/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Emergencies at 30,000 Feet: Air Force One, Pt. 2
https://reachmd.com/programs/clinicians-roundtable/emergencies-at-30000-feet-air-force-one-pt-2/1159/You're a healthcare professional and you've just answered the call to help a sick airline passenger while cruising at 30,000 feet. No resources; no support staff; no emergency landing for another 1/2 hour. No problem! You know what to do because you listen to boonDOCS Medicine... More specificaGuideline Recommendations for the Definition and Treatment of HER2-Low Breast Cancer
https://reachmd.com/programs/cme/guideline-recommendations-for-the-definition-and-treatment-of-her2-low-breast-cancer/29829/Join our expert faculty as they review the current guidelines for breast cancer and the clinical trial data supporting these recommendations.Managing Lupus: Tailored Strategies for Flares and Fatigue Relief
https://reachmd.com/programs/living-rheum/managing-lupus-tailored-strategies-for-flares-and-fatigue-relief/28632/Here’s how we can create personalized care plans for patients experiencing lupus flares and fatigue.Preventing Osteoporosis with Hormone Therapy: How to Select Appropriate Patients
https://reachmd.com/programs/frontlines-osteoporosis/preventing-osteoporosis-with-hormone-therapy-how-to-select-appropriate-patients/32331/Here are the key factors to consider when determining if a postmenopausal patient at risk of osteoporosis is an appropriate candidate for hormone therapy.Considerations for Using Opioids and Cannabis to Treat Chronic Pain
https://reachmd.com/programs/living-rheum/considerations-for-using-opioids-and-cannabis-to-treat-chronic-pain/24324/Here’s what clinicians should keep in mind when using opioids and cannabis to treat patients living with chronic pain.APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
https://reachmd.com/programs/acc-action-center/apoc3-aso-significantly-lowers-triglycerides-in-patients-with-hypertriglyceridemia-and-high-cv-risk/24294/ACC.24 - Brian Bergmark discusses the results of the BRIDGE-TIMI 73a trial in patients with either moderate hypertriglyceridemia and elevated CV risk or with severe hypertriglyceridemia. “Olezarsen reduced triglycerides levels to an extent that is greater than currently available drugs”.Stopping aspirin after 1 month DAPT in ACS patients after stenting
https://reachmd.com/programs/acc-action-center/stopping-aspirin-after-1-month-dapt-in-acs-patients-after-stenting/24290/ACC.24 - Study results from the ULTIMATE-DAPT show that aspirin can be stopped in ACS patients who underwent PCI and tolerated 1 month of DAPT -ticagrelor and aspirin- well. "You will be doing a favor for your patients," said Gregg Stone.